191 related articles for article (PubMed ID: 27191122)
1. Differences in Cognitive Outcomes After ECT Depending on BDNF and COMT Polymorphisms.
Bennett DM; Currie J; Fernie G; Perrin JS; Reid IC
J ECT; 2016 Dec; 32(4):243-250. PubMed ID: 27191122
[TBL] [Abstract][Full Text] [Related]
2. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
[TBL] [Abstract][Full Text] [Related]
3. Reply to Dr Martin's Letter Regarding Differences in Cognitive Outcomes After ECT Depending on BDNF and COMT Polymorphisms.
Bennett DM; Perrin JS; Fernie G
J ECT; 2017 Mar; 33(1):68-69. PubMed ID: 28181928
[No Abstract] [Full Text] [Related]
4. Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy.
Anttila S; Huuhka K; Huuhka M; Illi A; Rontu R; Leinonen E; Lehtimäki T
Pharmacogenomics J; 2008 Apr; 8(2):113-6. PubMed ID: 17700596
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder.
Huuhka K; Anttila S; Huuhka M; Leinonen E; Rontu R; Mattila K; Lehtimäki T
Eur Arch Psychiatry Clin Neurosci; 2007 Feb; 257(1):31-5. PubMed ID: 17036259
[TBL] [Abstract][Full Text] [Related]
6. Cognitive ability, intraindividual variability, and common genetic variants of catechol-O-methyltransferase and brain-derived neurotrophic factor: a longitudinal study in a population-based sample of older adults.
Das D; Tan X; Bielak AA; Cherbuin N; Easteal S; Anstey KJ
Psychol Aging; 2014 Jun; 29(2):393-403. PubMed ID: 24956006
[TBL] [Abstract][Full Text] [Related]
7. Association analysis of the catechol-O-methyltransferase /methylenetetrahydrofolate reductase genes and cognition in late-onset depression.
Wang X; Wang Z; Wu Y; Yuan Y; Hou Z; Hou G
Psychiatry Clin Neurosci; 2014 May; 68(5):344-52. PubMed ID: 24373005
[TBL] [Abstract][Full Text] [Related]
8. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
[TBL] [Abstract][Full Text] [Related]
9. Commentary on Bennett and Colleagues: Differences in Cognitive Outcomes After Electroconvulsive Therapy Depending on BDNF and COMT Polymorphisms.
Martin DM
J ECT; 2017 Mar; 33(1):68. PubMed ID: 28072663
[No Abstract] [Full Text] [Related]
10. Episodic Visual Learning/Memory and Attentional Flexibility in Patients With Major Depressive Disorder After Clinically Effective Electroconvulsive Therapy.
Kalogerakou S; Oulis P; Anyfandi E; Konstantakopoulos G; Papakosta VM; Kontis D; Theochari E; Angelopoulos E; Zervas IM; Mellon RC; Papageorgiou CC; Tsaltas E
J ECT; 2015 Dec; 31(4):246-52. PubMed ID: 25973768
[TBL] [Abstract][Full Text] [Related]
11. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Association Between Electrical Stimulation Dose, Subsequent Cognitive Function and Depression Severity in Patients Receiving Bilateral Electroconvulsive Therapy for Major Depressive Disorder.
Sinclair JE; Fernie G; Bennett DM; Reid IC; Cameron IM
J ECT; 2016 Sep; 32(3):159-63. PubMed ID: 27128722
[TBL] [Abstract][Full Text] [Related]
13. Genetic mechanisms of electroconvulsive therapy response in depression.
Benson-Martin JJ; Stein DJ; Baldwin DS; Domschke K
Hum Psychopharmacol; 2016 May; 31(3):247-51. PubMed ID: 27062668
[TBL] [Abstract][Full Text] [Related]
14. Gene×gene×gender interaction of BDNF and COMT genotypes associated with panic disorder.
Konishi Y; Tanii H; Otowa T; Sasaki T; Tochigi M; Umekage T; Motomura E; Shiroyama T; Kaiya H; Okazaki Y; Okada M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():119-25. PubMed ID: 24508446
[TBL] [Abstract][Full Text] [Related]
15. COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors.
Correa DD; Satagopan J; Cheung K; Arora AK; Kryza-Lacombe M; Xu Y; Karimi S; Lyo J; DeAngelis LM; Orlow I
Neuro Oncol; 2016 Oct; 18(10):1425-33. PubMed ID: 27091610
[TBL] [Abstract][Full Text] [Related]
16. BDNF and COMT polymorphisms have a limited association with episodic memory performance or engagement in complex cognitive activity in healthy older adults.
Stuart K; Summers MJ; Valenzuela MJ; Vickers JC
Neurobiol Learn Mem; 2014 Apr; 110():1-7. PubMed ID: 24468545
[TBL] [Abstract][Full Text] [Related]
17. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
Ryan KM; Dunne R; McLoughlin DM
Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
[TBL] [Abstract][Full Text] [Related]
18. BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression.
Viikki ML; Järventausta K; Leinonen E; Huuhka M; Mononen N; Lehtimäki T; Kampman O
Psychiatr Genet; 2013 Jun; 23(3):134-6. PubMed ID: 23532066
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
[TBL] [Abstract][Full Text] [Related]
20. Short- and Long-term Cognitive Outcomes in Patients With Major Depression Treated With Electroconvulsive Therapy.
Vasavada MM; Leaver AM; Njau S; Joshi SH; Ercoli L; Hellemann G; Narr KL; Espinoza R
J ECT; 2017 Dec; 33(4):278-285. PubMed ID: 28617690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
